RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD Q78.0ORPHA:666OI

Osteogenesis Imperfecta

Osteogenesis imperfecta (brittle bone disease) is a group of genetic conditions causing fragile bones that fracture easily. Most cases are caused by mutations in collagen genes. Severity ranges from mild to severe. Bisphosphonate therapy strengthens bones, and new treatments including gene-based approaches are in trials.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

536
Articles
59
Trials (7 AU)
Data refreshed
19 October 2026
Loading...

Common Questions

What is Osteogenesis Imperfecta?

Osteogenesis imperfecta (brittle bone disease) is a group of genetic conditions causing fragile bones that fracture easily. Most cases are caused by mutations in collagen genes. Severity ranges from mild to severe. Bisphosphonate therapy strengthens bones, and new treatments including gene-based approaches are in trials.

How many clinical trials are available for Osteogenesis Imperfecta?

RareWays currently indexes 59 clinical trials for Osteogenesis Imperfecta, of which 7 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Osteogenesis Imperfecta come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Osteogenesis Imperfecta.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.